focus -WSS

focus

author：leisure time 2025-09-30 20:18:32 - browse：37

Investment bank Goldman Sachs is jumping into the biotech world after raising $650 million to invest in privately held startups.

The bank announced Wednesday that it has closed its first-ever life sciences fund, called West Street Life Sciences I. The plan is to invest the money in genetic medicine, cell therapies, immunotherapies, synthetic biology and artificial intelligence startups, as well as diagnostics and life science tools companies.

First-time funds have been difficult to raise during the biotech downturn. Last year, around $11.6 billion was raised by 183 new VC funds, which was the lowest fundraising total for first-timers since 2013, according to Pitchbook. Around $25.6 billion had been raised by 556 first-time funds in 2022.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Cheap, fast test for Zika and dengue could cost just $1

WSS

My daughter's legacy lives on through her writing, phage therapy

Key House panel plots a new health care package

WHO calls for emergency meeting on new China virus, as cases spread

'Essentially witchcraft:' A former naturopath takes on the field

WHO calls for emergency meeting on new China virus, as cases spread

Biden tests positive for Covid

focus

focus

hotspot

Duchenne breakthrough therapy leaves behind pioneering families

New report analyzes digital physical therapy solutions' effectiveness

Cancer drug shortages should be causing more outrage

Stephen Quake on the Chan Zuckerberg quest to conquer disease

Continuity nursing helped my family in our darkest PICU moments

Coercive sterilizations revealed by STAT prompt outrage

Heart attack and stroke risk calculators need revising

Coercive sterilizations revealed by STAT prompt outrage

Virginia high school admissions case could be legal follow

FDA approves RSV monoclonal antibody for infants, toddlers

focus

Health care court cases: Humana, Sutter, Novant

Health care court cases: Humana, Sutter, Novant

Sanders adds drug shortage policies to pandemic preparedness bill

Curing rare childhood diseases will falter unless Congress steps up

The system is set up to fail children with medical complexity

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

explore

Wikipedia

leisure time

entertainment